Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder

References

• Black RJ, Bray F, Ferloy J, Parkin DM. Cancer incidence and mortality in the European Union Cancer registry data and estimates of national incidence for. Eur J Cancer ;33 1990; 1997: 1075–107
   Google Scholar
• Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006; 49: 466–77
   PubMed Web of Science ®Google Scholar
• Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou J. Guidelines on TaT1 (non-muscle invasive) bladder cancer. European Association of Urology, ArnhemThe Netherlands 2008
   Google Scholar
• Shahin O, Thalmann GN, Rentsch C, Mazzucchelli L, Studer UE. A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. J Urol 2003; 169: 96–100
   PubMed Web of Science ®Google Scholar
• Santos L, Costa C, Pereira S, Koch M, Amaro T, Cardoso F. Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumours. Ann Oncol 2003; 14: 1419–24
   PubMed Web of Science ®Google Scholar
• Herr HW, Sogani PC. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?. J Urol 2001; 166: 1296–9
   PubMed Web of Science ®Google Scholar
• Hurle R, Losa A, Manzetti A, Lembo A. Intravesical bacillus Calmette-Guerin in stage T1, grade 3 bladder cancer therapy: a 7-year follow-up. Urology 1999; 54: 258–63
   PubMed Web of Science ®Google Scholar
• Lebret T, Gaudez F, Hervé JM, Barré P, Lugagne PM, Botto H. Low-dose BCG instillations in the treatment of Stage T1 Grade 3 bladder tumours: recurrence, progression and success. Eur Urol 1998; 34: 67–72
   PubMed Web of Science ®Google Scholar
• Brake M, Loertzer H, Horsch R, Keller H. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin. J Urol 2000; 163: 1697–701
   PubMed Web of Science ®Google Scholar
• Pansadoro V, Emiliozzi P, de Paula F, Scarpone P, Pansadoro A, Sternberg CN. Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guerin: 18-year experience. Urology 2002; 59: 227–31
   PubMed Web of Science ®Google Scholar
• Denzinger S, Fritsche HM, Otto W, Blana A, Wieland WF, Burger M. Early versus deferred cystectomy for initial high-risk pt1g3 urothelial carcinoma of the bladder: do risk factors define feasibility of bladder-sparing approach?. Eur Urol 2008; 53: 146–52
   PubMed Web of Science ®Google Scholar
• Denzinger S, Burger M, Fritsche HM, Ganzer R, Blana A, Wieland WF, et al. Bladder preservation or initial cystectomy in T1G3 bladder cancer: which parameters help in therapeutic decision-making?. Aktuel Urol 2008; 38: 58–61
   Web of Science ®Google Scholar
• Thalmann G. Organ preservation for T1G3 bladder cancer: is it feasible?. Eur Urol 2008; 53: 27–9
   PubMed Web of Science ®Google Scholar
• Malavaud B. T1G3 bladder tumours: the case for radical cystectomy. Eur Urol 2004; 45: 406–10
   PubMed Web of Science ®Google Scholar
• Turner W. T1G3 bladder tumours: the case for conservative treatment. Eur Urol 2004; 45: 401–5
   PubMed Web of Science ®Google Scholar
• Mhawech P, Iselin C, Pelte MF. Value of immunohistochemistry in staging T1 urothelial bladder carcinoma. Eur Urol 2002; 42: 459–63
   PubMed Web of Science ®Google Scholar
• Orsola A, Trias I, Raventos CX, Español I, Cecchini L, Búcar S, et al. Initial High-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Eur Urol 2005; 48: 231–8
   PubMed Web of Science ®Google Scholar
• Kondylis FI, Demirci S, Ladaga L, Kolm P, Schellhammer PF. Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma. J Urol 2000; 130: 1120–3
   Google Scholar
• Jimenez RE, Gheiler E, Oskanian P, Tiquert R, Sakr W, Wood DP. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 2000; 24: 980–7
   PubMed Web of Science ®Google Scholar
• Krüger S, Noack F, Böhle A, Feller AC. Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder. Oncol Rep 2004; 12: 609–13
   PubMed Web of Science ®Google Scholar
• Denzinger S, Wieland WF, Otto W, Filbeck T, Knuechel R, Burger M. Does photodynamic transurethral resection of bladder tumour improve the outcome of initial T1 high-grade bladder cancer? A long-term follow-up of a randomized study. BJU Int 2008; 101: 566–69
   PubMed Web of Science ®Google Scholar
• Langner C, Hutterer G, Chromecki T, Rehak P, Zigeuner R. Patterns of invasion and histopathological growth as prognostic indicators in urothelial carcinoma of the upper urinary tract. Virchows Arch 2006; 448: 604–11
   PubMed Web of Science ®Google Scholar
• Bircan S, Candir O, Kapucuoglu N. The effect of tumor invasion patterns on pathologic stage of bladder urothelial carcinomas. Path Oncol Res 2005; 11: 87–91
   PubMed Web of Science ®Google Scholar
• Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T. Opinion: migrating cancer stem cells – an integrated concept of malignant tumour progression. Nat Rev Cancer 2005; 5: 744–749
   PubMed Web of Science ®Google Scholar
• Baumgart E, Cohen MS, Silva Neto B, Jacobs MA, Wotkowicz C, Rieger-Christ KM, et al. Identification and prognostic significance of an epithelial–mesenchymal transition expression profile in human bladder tumors. Clin Cancer Res 2007; 13: 1685–94
   PubMed Web of Science ®Google Scholar